Donna Headlee
Impact in
- Oncology top 2%
- Cancer-related Molecular Pathways
- Biotechnology top 2%
Papers in
-
- Histone Deacetylase Inhibitors Research 2
-
- Prostate Cancer Treatment and Research 5
- Co-authors
- William D. Figg (20 shared papers)Edward A. Sausville (16 shared papers)Adrian M. Senderowicz (15 shared papers)A Tompkins (8 shared papers)Susan G. Arbuck (8 shared papers)Seth M. Steinberg (8 shared papers)William D. Figg (10 shared papers)Michael R. Cooper (10 shared papers)
- Journals
- Journal of Clinical Oncology (5 papers)Cancer (4 papers)Cancer Chemotherapy and Pharmacology (3 papers)Blood (2 papers)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesMalaysiaJapan
In The Last Decade
Donna Headlee
34 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 97
- Oncology 997
- Biotechnology 217
- Molecular Biology 1.4k
- Cancer Research 276
- Genetics 193
Countries citing papers authored by Donna Headlee
This map shows the geographic impact of Donna Headlee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donna Headlee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donna Headlee more than expected).
Fields of papers citing papers by Donna Headlee
This network shows the impact of papers produced by Donna Headlee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donna Headlee. The network helps show where Donna Headlee may publish in the future.
Co-authors
The 25 scholars most cited alongside Donna Headlee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 361 | |
| 2 | 1998 | 356 | |
| 3 | 2001 | 249 | |
| 4 | Unpredicted clinical pharmacology of UCN-01 caused by specific binding to human alpha1-acid glycoprotein. | 1998 | 182 |
| 5 | 1995 | 146 | |
| 6 | A phase I and pharmacokinetic study of intravenous phenylacetate in patients with cancer. | 1994 | 145 |
| 7 | 1996 | 130 | |
| 8 | 1994 | 120 | |
| 9 | 1995 | 116 | |
| 10 | 2002 | 109 | |
| 11 | A phase I study of combination therapy with immunotoxins IgG-HD37-deglycosylated ricin A chain (dgA) and IgG-RFB4-dgA (Combotox) in patients with refractory CD19(+), CD22(+) B cell lymphoma. | 2000 | 104 |
| 12 | 1999 | 103 | |
| 13 | A Phase II study of high-dose tamoxifen in patients with hormone-refractory prostate cancer. | 1999 | 84 |
| 14 | 1998 | 79 | |
| 15 | 1995 | 65 | |
| 16 | 1995 | 57 | |
| 17 | 1997 | 48 | |
| 18 | 1995 | 42 | |
| 19 | 1992 | 39 | |
| 20 | 2003 | 38 |
About Donna Headlee
Donna Headlee is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Endocrinology, Diabetes and Metabolism and Immunology, having authored 34 papers that have together received 2.8k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (5 papers), Toxin Mechanisms and Immunotoxins (4 papers), Cancer, Lipids, and Metabolism (3 papers), Hormonal and reproductive studies (2 papers), Neuroblastoma Research and Treatments (2 papers), Transgenic Plants and Applications (2 papers), Adrenal Hormones and Disorders (2 papers) and Histone Deacetylase Inhibitors Research (2 papers). The work is most often cited by research in Oncology (997 citations), Biotechnology (217 citations), Molecular Biology (1.4k citations), Cancer Research (276 citations) and Genetics (193 citations). Donna Headlee has collaborated with scholars based in United States, Malaysia and Japan. Frequent co-authors include William D. Figg, Edward A. Sausville, Adrian M. Senderowicz, A Tompkins, Susan G. Arbuck, Seth M. Steinberg, William D. Figg, Michael R. Cooper, Alain Thibault and Richard M. Lush. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Cancer Chemotherapy and Pharmacology, Blood and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.